PUBLISHER: IMARC | PRODUCT CODE: 1729283
PUBLISHER: IMARC | PRODUCT CODE: 1729283
The Japan organ preservation market size reached USD 3.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5.1 Million by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033.
Organ preservation refers to the procedure of preserving the viable organs harvested from the body of a donor to be later transplanted into the body of a receiver. The organ preservation process involves various techniques for storage and transportation purposes, such as static cold storage (SCS), normothermic machine perfusion (NMP), and hypothermic machine perfusion. These procedures prevent harmful metabolites from breaking down healthy tissues and maintain the temperature and oxygen levels of the organ, thereby increasing the survival rate of the receiver. They are also flushed with preservative solutions that are essential in resorting the normal organ functionality post-transplantation.
Rising occurrences of multiple organ failures due to the growing prevalence of various chronic diseases, such as cardiovascular diseases, diabetes, and obesity, represent one of the key factors driving the Japan organ preservation market. Additionally, significant expansion in the medical sector with a rise in the per capita expenditure on medical services, is also supporting the market growth in the country. Moreover, rapid technological advancements, including the development of normothermic machine perfusion (NMP) to reduce the risk of repercussion injury during transplantation, is acting as another growth-inducing factor. Furthermore, the Government of Japan (GoJ) is undertaking initiatives to promote organ donation, which is creating a positive outlook for the market.
The competitive landscape of the industry has also been examined along with the profiles of the key players.